Immune reconstruction effectiveness of combination antiretroviral therapy for HIV-1 CRF01_AE cluster 1 and 2 infected individuals

References

• Taylor BS, Sobieszczyk ME, McCutchan FE, et al. The challenge of HIV-1 subtype diversity. New England Journal of Medicine. 2008;358(15):1590–1602.
   PubMed Web of Science ®Google Scholar
• McCutchan FE, Hegerich PA, Brennan TP, et al. Genetic variants of HIV-1 in Thailand. AIDS Res Hum Retroviruses. 1992 Nov;8(11):1887–95.
   PubMed Web of Science ®Google Scholar
• Carr JK, Salminen MO, Koch C, et al. Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand. J Virol. 1996 Sep;70(9):5935–43.
   PubMed Web of Science ®Google Scholar
• Gao F, Robertson DL, Morrison SG, et al. The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol. 1996 Oct;70(10):7013–29.
   PubMed Web of Science ®Google Scholar
• McCutchan FE, Artenstein AW, Sanders-Buell E, et al. Diversity of the envelope glycoprotein among human immunodeficiency virus type 1 isolates of clade E from Asia and Africa. J Virol. 1996 Jun;70(6):3331–8.
   PubMed Web of Science ®Google Scholar
• Hemelaar J, Elangovan R, Yun J, et al. Global and regional molecular epidemiology of HIV-1, 1990-2015: a systematic review, global survey, and trend analysis. The Lancet Infectious Diseases. 2019 Feb;19(2):143–155.
   PubMed Web of Science ®Google Scholar
• He X, Xing H, Ruan Y, et al. A comprehensive mapping of HIV-1 genotypes in various risk groups and regions across China based on a nationwide molecular epidemiologic survey. PloS one. 2012;7(10):e47289.
   PubMed Web of Science ®Google Scholar
• Feng Y, He X, Hsi JH, et al. The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s. AIDS (London. England. 2013;27(11):1793.
   Web of Science ®Google Scholar
• Hui X, PanPinliang SL, Xiujuan F. Molecular epidemiological study of a HIV-1 strain of subtype E in China between 1996 and 1998. Journal for China Aids/std. 2002;4:4.
   Google Scholar
• Chu M, Zhang W, Zhang X, et al. HIV-1 CRF01_AE strain is associated with faster HIV/AIDS progression in Jiangsu province, China. Scientific Reports. 2017;7(1):1–8.
   PubMedGoogle Scholar
• Li X, Xue Y, Zhou L, et al. Evidence that HIV-1 CRF01_AE is associated with low CD4+ T cell count and CXCR4 co-receptor usage in recently infected young men who have sex with men (MSM) in Shanghai, China. PloS one. 2014 Feb 21;9(2):e89462.
   PubMed Web of Science ®Google Scholar
• Weiser B, Philpott S, Klimkait T, et al. HIV-1 coreceptor usage and CXCR4-specific viral load predict clinical disease progression during combination antiretroviral therapy. Aids. 2008;22(4):469–479.
   PubMed Web of Science ®Google Scholar
• Li Y, Han Y, Xie J, et al. CRF01_AE subtype is associated with X4 tropism and fast HIV progression in Chinese patients infected through sexual transmission. Aids. 2014;28(4):521–530.
   PubMed Web of Science ®Google Scholar
• Ng KY, Chew KK, Kaur P, et al. High prevalence of CXCR4 usage among treatment-naive CRF01_AE and CRF51_01B-infected HIV-1 subjects in Singapore. BMC Infectious Diseases. 2013;13(1):90.
   PubMed Web of Science ®Google Scholar
• Scherrer AU, Ledergerber B, von Wyl V, et al. Improved virological outcome in white patients infected with HIV-1 non-B subtypes compared to subtype B. Clinical Infectious Diseases. 2011;53(11):1143–1152.
   PubMed Web of Science ®Google Scholar
• Lee LK, Lin L, Chua A, et al. Poorer immunologic outcome on treatment among patients infected with HIV-1 non-B subtypes compared with subtype B in Singapore. Clinical Infectious Diseases. 2012;54(12):1818–1820.
   PubMed Web of Science ®Google Scholar
• Langford SE, Ananworanich J, Cooper DA. Predictors of disease progression in HIV infection: a review. AIDS Research and Therapy. 2007;4(1):11.
   PubMedGoogle Scholar
• Song H, Ou W, Feng Y, et al. Disparate impact on CD4 T cell count by two distinct HIV-1 phylogenetic clusters from the same clade. Proceedings of the National Academy of Sciences. 2019;116(1):239–244.
   PubMed Web of Science ®Google Scholar
• Li X, Liu H, Liu L, et al. Tracing the epidemic history of HIV-1 CRF01_AE clusters using near-complete genome sequences. Scientific Reports. 2017;7(1):1–11.
   PubMed Web of Science ®Google Scholar
• Li J, Feng Y, Shen Z, et al. HIV-1 transmissions among recently infected individuals in Southwest China are predominantly derived from circulating local strains. Scientific Reports. 2018;8(1):1–9.
   PubMed Web of Science ®Google Scholar
• Chen M, Ma Y, Su Y, et al. HIV-1 genetic characteristics and transmitted drug resistance among men who have sex with men in Kunming, China. PLoS One. 2014;9(1):e87033.
   PubMed Web of Science ®Google Scholar
• He X, Xing H, Ruan Y, et al. A comprehensive mapping of HIV-1 genotypes in various risk groups and regions across China based on a nationwide molecular epidemiologic survey. Plos One. 2012;7(10):e47289.
   PubMed Web of Science ®Google Scholar
• Stéphane H, Brown AE, Manon RC, et al. Phylogenetic analyses reveal HIV-1 infections between men misclassified as heterosexual transmissions. Aids. 2014;28(13):1967–75.
   PubMed Web of Science ®Google Scholar
• Chen J, Wong K, Li P, et al. Molecular epidemiological study of HIV-1 CRF01_AE transmission in Hong Kong. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2009;51(5):530–535.
   PubMed Web of Science ®Google Scholar
• Han X, Dai D, Zhao B, et al. Genetic and epidemiologic characterization of HIV-1 infection in Liaoning province, China. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2010;53:S27–S33.
   PubMed Web of Science ®Google Scholar
• Price MN, Dehal PS, Arkin AP. Fasttree: computing large minimum evolution trees with profiles instead of a distance matrix. Molecular Biology and Evolution. 2009;26(7):1641–1650.
   PubMed Web of Science ®Google Scholar
• Hwang SS, Boyle TJ, Lyerly HK, et al. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science. 1991;253(5015):71–74.
   PubMed Web of Science ®Google Scholar
• Lengauer T, Sander O, Sierra S, et al. Bioinformatics prediction of HIV coreceptor usage. Nature Biotechnology. 2007;25(12):1407–1410.
   PubMed Web of Science ®Google Scholar
• Zhang F, Zhu H, Wu Y, et al. HIV, hepatitis B virus, and hepatitis C virus co-infection in patients in the China National free antiretroviral treatment program, 2010–12: a retrospective observational cohort study. The Lancet Infectious Diseases. 2014;14(11):1065–1072.
   PubMed Web of Science ®Google Scholar
• Zhong P, Pan Q, Ning Z, et al. Genetic diversity and drug resistance of human immunodeficiency virus type 1 (HIV-1) strains circulating in Shanghai. AIDS Research and Human Retroviruses. 2007;23(7):847–856.
   PubMed Web of Science ®Google Scholar
• Kelley CF, Kitchen CM, Hunt PW, et al. Incomplete peripheral CD4 + cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clinical Infectious Diseases. 2009;48(6):787–794.
   PubMed Web of Science ®Google Scholar
• Wie SH, Kim NJ, Bang JH, et al. The 2018 clinical guidelines for the diagnosis and treatment of HIV/AIDS in HIV-infected Koreans. Infection and Chemotherapy. 2019;51(1):77–88.
   PubMed Web of Science ®Google Scholar
• Ananthaswamy N, Fang Q, AlSalmi W, et al. A sequestered fusion peptide in the structure of an HIV-1 transmitted founder envelope trimer. Nature Communications. 2019 Feb 20;10(1):873.
   PubMed Web of Science ®Google Scholar
• Tamamis P, Floudas CA. Molecular recognition of CXCR4 by a dual tropic HIV-1 gp120 V3 loop. Biophysical Journal. 2013 Sep 17;105(6):1502–14.
   PubMed Web of Science ®Google Scholar
• Cui H, Geng W, Sun H, et al. Rapid CD4+ T-cell decline is associated with coreceptor switch among MSM primarily infected with HIV-1 CRF01_AE in Northeast China. Aids. 2019;33(1):13–22.
   PubMed Web of Science ®Google Scholar
• Bader J, Schöni-Affolter F, Böni J, et al. Correlating HIV tropism with immunological response under combination antiretroviral therapy. HIV Medicine. 2016;17(8):615–622.
   PubMed Web of Science ®Google Scholar
• Ng OT, Lin L, Laeyendecker O, et al. Increased rate of CD4+ T-cell decline and faster time to antiretroviral therapy in HIV-1 subtype CRF01_AE infected seroconverters in Singapore. PloS one. 2011 Jan 27;6(1):e15738.
   PubMed Web of Science ®Google Scholar
• An M, Han X, Zhao B, et al. Cross-Continental dispersal of major HIV-1 CRF01_AE clusters in China. Frontiers in Microbiology. 2020;11:61.
   PubMed Web of Science ®Google Scholar
• Jiao Y, Song Y, Kou B, et al. Primary CXCR4 co-receptor use in acute HIV infection leads to rapid disease progression in the AE subtype. Viral Immunology. 2012;25(4):262–267.
   PubMed Web of Science ®Google Scholar
• Tanuma J, Matsumoto S, Haneuse S, et al. Long-term viral suppression and immune recovery during first-line antiretroviral therapy: a study of an HIV-infected adult cohort in Hanoi, Vietnam. Journal of the International AIDS Society. 2017;20(4):e25030.
   PubMed Web of Science ®Google Scholar
• Moore RD, Keruly JC. CD4 + cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clinical Infectious Diseases. 2007;44(3):441–446.
   PubMed Web of Science ®Google Scholar
• Althoff KN, Justice AC, Gange SJ, et al. Virologic and immunologic response to HAART, by age and regimen class. AIDS (London. England. 2010;24(16):2469.
   Web of Science ®Google Scholar
• Boatman JA, Baker JV, Emery S, et al. Risk factors for Low CD4+ count recovery despite viral suppression Among participants initiating antiretroviral treatment With CD4+ counts> 500 cells/mm3: findings from the strategic timing of AntiRetroviral therapy (START) trial. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2019;81(1):10–17.
   PubMed Web of Science ®Google Scholar
• Guo J, Yan Y, Zhang J, et al. Co-receptor tropism and genetic characteristics of the V3 regions in variants of antiretroviral-naive HIV-1 infected subjects. Epidemiology & Infection. 2019 Jan;147:e181.
   PubMed Web of Science ®Google Scholar
• Ge Z, Feng Y, Li K, et al. CRF01_AE and CRF01_AE cluster 4 are associated with poor immune recovery in Chinese patients under cART. Clinical Infectious Diseases. 2021 May 18;72(10):1799–1809.
   PubMed Web of Science ®Google Scholar